comparemela.com

Latest Breaking News On - Olaparib tablets - Page 1 : comparemela.com

AstraZeneca: India s drug regulator orders withdrawal of AstraZeneca s cancer drug due to potential adverse effects |

DCGI orders withdrawal of AstraZeneca's Olaparib tablets for gBRCA mutation and advanced ovarian cancer due to potential adverse effects. The drug was

Abhishek shankarDepartment of radiation oncologyAstrazeneca pharma indiaDr br ambedkar institute rotary cancer hospitalDrug controller generalAstrazeneca pharma india limitedOlaparib tabletsAssistant professorRadiation oncologyInstitute rotary cancer hospital

DCGI orders withdrawal of cancer drug Olaparib for certain treatments

The communication stated that the firm presented the clinical evidence for the withdrawal of indication of Olaparib tablets.

New delhiAstrazeneca pharma indiaDrug controller generalAstrazeneca pharma india limitedOlaparib tablets

cancer drugs | Drug Controller General of India orders withdrawal of AstraZeneca anti-cancer drug Olaparib tablets for certain treatments

cancer drugs | Drug Controller General of India orders withdrawal of AstraZeneca anti-cancer drug Olaparib tablets for certain treatments
telegraphindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from telegraphindia.com Daily Mail and Mail on Sunday newspapers.

Astrazeneca pharma indiaDrug controller generalAstrazeneca pharma india limitedOlaparib tablets

CGI orders withdrawal of cancer drug Olaparib for certain treatments

cgi orders withdrawal of cancer drug olaparib for certain treatments

New delhiAstrazeneca pharma indiaDrug controller generalAstrazeneca pharma india limitedOlaparib tablets

India News | DCGI Orders Withdrawal of Cancer Drug Olaparib for Certain Treatments

Get latest articles and stories on India at LatestLY. The Drug Controller General of India has asked drug regulators in all states and Union territories to withdraw AstraZeneca's anti-cancer drug Olaparib tablets for treatment in patients who have received three or more prior lines of chemotherapy. India News | DCGI Orders Withdrawal of Cancer Drug Olaparib for Certain Treatments.

New delhiAstrazeneca pharma indiaDrug controller generalAstrazeneca pharma india limitedOlaparib tablets

vimarsana © 2020. All Rights Reserved.